> The first lots of Sanofi's Fluzone vaccine for the 2014-2015 influenza season have been released for distribution. Release
> 84% of the world's infants received vaccines in 2013, missing the Global Vaccine Action Plan's 90% goal, according to WHO. Report
> In a Phase I/IIa trial, Genocea's ($GNCA) herpes vaccine elicited significant, durable T-cell response. Release
> Mymetics ($MYMX) has agreed to manufacture Imugene's cancer vaccine, HER-Vaxx. Story
> Researchers have created a vaccine for dust-mite allergies. More
And Finally... Scientists have identified a biomarker that may predict HIV vaccine efficacy. Story | More from FierceDiagnostics